Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Current treatment standards for primary ovarian cancer

Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
Current treatment standards for primary ovarian cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )
18 Feb 2021

Evolving medical treatment in advanced/recurrent endometrial cancer

Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
Evolving medical treatment in advanced/recurrent endometrial cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )
18 Feb 2021

Reduced intensity allogeneic HSCT to hypomethylating therapy or best supportive care in older patients with advanced MDS

Dr Ryotaro Nakamura - City of Hope, California, USA
Reduced intensity allogeneic HSCT to hypomethylating therapy or best supportive care in older patients with advanced MDS ( Dr Ryotaro Nakamura - City of Hope, California, USA )
17 Feb 2021

ITACA NSCLC study: Final results

Prof Silvia Novello - University of Turin, Turin, Italy
ITACA NSCLC study: Final results ( Prof Silvia Novello - University of Turin, Turin, Italy )
16 Feb 2021

Renal liposarcoma: Case report and review of systemic treatment

Dr Abel Centurion - Peruvian National Cancer Institute, Surquillo, Peru
Renal liposarcoma: Case report and review of systemic treatment ( Dr Abel Centurion -  Peruvian National Cancer Institute, Surquillo, Peru )
16 Feb 2021

KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic NSCLC

Prof Michael Boyer - Chris O’Brien Lifehouse, Sydney, Australia
KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic NSCLC ( Prof Michael Boyer - Chris O’Brien Lifehouse, Sydney, Australia )
16 Feb 2021

TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair alterations and mCRPC

Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France
TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair alterations and mCRPC ( Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France )
15 Feb 2021

ASCO GU 2021: Renal cancer roundup

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ASCO GU 2021: Renal cancer roundup ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
15 Feb 2021

OncoAlert and ecancer weekly roundup for February 01 - 06, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for February 01 - 06, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
9 Feb 2021

Latest in EGFR-positive NSCLC with exon 20 insertion mutations

Prof Sanjay Popat, Prof Michael Thomas, Dr Marina Garassino, Dr Rosario Campelo, Dr Enriqueta Felip
Latest in EGFR-positive NSCLC with exon 20 insertion mutations ( Prof Sanjay Popat, Prof Michael Thomas, Dr Marina Garassino, Dr Rosario Campelo, Dr Enriqueta Felip )
9 Feb 2021

WCLC 2020 overview

Dr Luis Raez - Memorial Healthcare System, Hollywood, FL, USA
WCLC 2020 overview ( Dr Luis Raez - Memorial Healthcare System, Hollywood, FL, USA )
5 Feb 2021

Emergence of PARP inhibitors in prostate cancer

Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK
Emergence of PARP inhibitors in prostate cancer ( Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK )
5 Feb 2021